Supreme Court: Socialized Medicine OK in Maine

2 posts / 0 new
Last post
Supreme Court: Socialized Medicine OK in Maine

While this law isn't exactly "socialized medicine," -- it is another liberal [i]stepping stone[/i] along the way towards a fully govt-run medical system (aka: [i]HillaryCare[/i].)It will undoubtedly increase cost-shifting in the health care business from the camsexx govt programs to the privately insured...
which makes private plans more expensive...
which means more people will have to drop them...
which creates a larger "crisis"...
with more people uninsured......and if they have it all timed just right - the snowballing health care crisis will be at its worst in an election year! And the liberals will ride in with a "solution" to the problems they've created for the last decades.Just watch!!! [i]You know it's coming.[/i]

Supreme Court: Socialized Medicine OK in Maine

Court Rules Against Drug Cos on Maine Law
Monday May 19, 11:40 am ET
By James Vicini WASHINGTON (Reuters) - The U.S. Supreme Court ruled on Monday that the pharmaceutical industry was unlikely to succeed in its challenge to a pioneering Maine law designed to lower prescription drug prices for the poor and uninsured.

The ruling dealt at least a temporary setback to the drug industry, which had argued that the state law conflicted with the federal Medicaid law and that Maine program violated the U.S. Constitution because it interfered with interstate commerce.Every pharmaceutical stock traded lower on the news, analysts said."At this stage of the litigation, petitioner (the drug industry) has not carried its burden of showing a probability of success on the merits of its claims," Justice John Paul Stevens said for the court majority.The program, known as Maine Rx, would allow the state to negotiate bulk discounts from drug makers in an effort to provide affordable prescription drugs for an estimated 325,000 residents who don't have insurance.A prior-authorization provision would threaten drug makers that refuse to negotiate with the possibility that special permission would be required before their products could be prescribed for patients in the Medicaid health insurance program.A growing concern that many Maine residents, who were not Medicaid recipients, could not afford needed prescription drugs led to the law's adoption in 2000.The law has yet to go into effect because of the court challenge by the Pharmaceutical Research and Manufacturers of America, a drug industry trade group.The Supreme Court's ruling set aside the injunction, allowing the law to go into effect, but the ruling left open the possibility of further challenges, and the court did not express an opinion on the ultimate fate of the law.The high court affirmed a ruling by a federal appeals court in Boston that upheld the law.An estimated 70 million Americans do not have prescription drug coverage and are forced to pay the highest prices for medications because they are not represented by anyone to negotiate prices, supporters of the Maine law said.They predicted the program could lower prescription drug costs by as much as 30 percent for uninsured residents.More than half of the states and AARP (News - Websites), the lobbying group for those 50 or older, supported Maine while business groups backed the drug industry.Shares of Bristol-Myers Squibb (NYSE:BMY - News), Pfizer Inc. (NYSE :p FE - News) and Eli Lilly and Co. (NYSE:LLY - News) were all off more than 5 percent, leading the American Stock Exchange Pharmaceutical Index (AMEX:^DRG - News) to a 4 percent decline Monday.

Log in to post comments